UBS Group AG - NOVABAY PHARMACEUTICALS INC ownership

NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 26 filers reported holding NOVABAY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NOVABAY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
4,465
-22.5%
0.00%
Q2 2022$1,000
-66.7%
5,761
-41.3%
0.00%
Q1 2022$3,000
-92.3%
9,809
-83.0%
0.00%
Q2 2021$39,000
+85.7%
57,592
+140.1%
0.00%
Q1 2021$21,000
+200.0%
23,989
+131.7%
0.00%
Q4 2020$7,000
+600.0%
10,353
+417.6%
0.00%
Q3 2020$1,000
-96.3%
2,000
-91.5%
0.00%
Q2 2020$27,000
+1250.0%
23,460
+649.5%
0.00%
Q1 2020$2,000
-81.8%
3,130
-82.4%
0.00%
Q4 2019$11,000
+1000.0%
17,826
+791.3%
0.00%
Q3 2019$1,000
-91.7%
2,000
-73.4%
0.00%
Q2 2019$12,000
+50.0%
7,506
+11.6%
0.00%
Q1 2019$8,000
+166.7%
6,728
+74.2%
0.00%
Q4 2018$3,000
-40.0%
3,863
+49.6%
0.00%
Q3 2018$5,000
-37.5%
2,583
-15.7%
0.00%
Q2 2018$8,0000.0%3,065
+28.0%
0.00%
Q1 2018$8,000
-33.3%
2,394
-22.8%
0.00%
Q4 2017$12,000
+300.0%
3,100
+258.4%
0.00%
Q2 2017$3,000
-72.7%
865
-68.9%
0.00%
Q1 2017$11,0002,777
+3371.2%
0.00%
Q4 2016$0
-100.0%
80
-97.2%
0.00%
Q2 2016$7,000
+75.0%
2,833
+27.6%
0.00%
Q4 2015$4,0002,2200.00%
Other shareholders
NOVABAY PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
VANGUARD GROUP INC 38,947$79,0000.00%
UBS Group AG 2,220$4,0000.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 80$00.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
DEUTSCHE BANK AG\ 5,691$11,0000.00%
CITIGROUP INC 5,504$11,0000.00%
MORGAN STANLEY 100$00.00%
MSI Financial Services Inc 24$00.00%
Renaissance Technologies 19,924$40,0000.00%
View complete list of NOVABAY PHARMACEUTICALS INC shareholders